Cantor Fitzgerald Reiterates Overweight on 89bio, Maintains $29 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on 89bio (NASDAQ:ETNB) and maintained a price target of $29.
September 20, 2024 | 4:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated its Overweight rating on 89bio, maintaining a price target of $29, indicating confidence in the company's potential for growth.
The reiteration of an Overweight rating and a maintained price target of $29 by a reputable analyst suggests positive sentiment and potential upside for 89bio's stock. This could lead to increased investor interest and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100